<DOC>
	<DOCNO>NCT01556854</DOCNO>
	<brief_summary>The primary objective study compare effectiveness five different neuroprotectants , include butylphthalide , edaravone , citicoline , cerebrolysin , piracetam , among patient acute ischemic stroke . The secondary objective study follow : - To compare safety five different neuroprotectents , include butylphthalide , edaravone , citicoline , cerebrolysin , piracetam , among patient acute ischemic stroke . - To compare cost-effectiveness five different neuroprotectents , include butylphthalide , edaravone , citicoline , cerebrolysin , piracetam , among patient acute ischemic stroke .</brief_summary>
	<brief_title>Comparative Effectiveness Neuroprotectants Acute Ischemic Stroke</brief_title>
	<detailed_description>Study Population : The study population consist consent patient neuroprotectant injection treatment acute IS hospitalization . Hospitals may contribute differ number patient total sample size . Primary analysis conduct total sample size . Assessment Outcomes : The outcome measure study include effectiveness , safety cost measure .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Neuroprotective Agents</mesh_term>
	<criteria>At least 18 year old Ischemic stroke confirm brain CT MRI within 14 day index event Neuroprotectents administrate hospitalization Direct admission base physician evaluation arrival emergency department Ability patient legally authorize representative ( primarily spouse , parent , adult child , otherwise indicate ) provide inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>ginkgo leaf</keyword>
	<keyword>butylphthalide</keyword>
	<keyword>edaravone</keyword>
	<keyword>citicoline</keyword>
	<keyword>cerebrolysin</keyword>
	<keyword>piracetam</keyword>
	<keyword>Neuroprotectants</keyword>
</DOC>